Related Experiment Video
Updated: Jun 13, 2025
05:51
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
Published on: May 23, 2019
5.9K
Live-cell visualization of tau aggregation in human neurons
Bryan Hurtle1,2, Christopher J Donnelly1,3,4,5,6, Xin Zhang7
1Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Communications Biology
|September 14, 2024
Summary
Researchers developed optoTAU, a light-responsive tau protein, to study Alzheimer's disease and tauopathies. This tool helps understand tau aggregation
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Alzheimer's disease (AD) and tauopathies are characterized by insoluble tau protein (MAPT) aggregates.
- The specific tau species responsible for neurotoxicity remain incompletely understood.
- Understanding tau aggregation is crucial for developing effective treatments.
Purpose of the Study:
- To develop a novel tool for studying tau aggregation in live cells.
- To investigate the consequences of tau aggregation in human neurons.
- To identify potential modifiers of tau aggregation relevant to AD and tauopathies.
Main Methods:
- Development of a light-responsive tau protein (optoTAU).
- Utilized viscosity-sensitive AggFluor probes to monitor tau aggregation.
- Investigated tau aggregation dynamics in human neurons.
Main Results:
- optoTAU successfully replicated biological and structural properties of tau aggregation seen in human brains.
- Demonstrated the pathophysiological transition in tau solubility within live cells.
- Provided proof-of-concept for optoTAU as a pharmacological platform to identify aggregation modifiers.
Conclusions:
- optoTAU is a valuable tool for studying tauopathies and Alzheimer's disease.
- Findings advance the understanding of protein aggregation, solubility, and disease progression.
- optoTAU offers a new avenue for therapeutic target identification in neurodegenerative diseases.
